Stock-Based Compensation and Other Employee Benefits - Additional Plans (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Share-Based Payment Arrangement [Abstract] | |||
| Aggregate intrinsic value of options exercised | $ 9,775 | $ 33,494 | $ 19,762 |
| Cash received from stock option exercises | $ 3,954 | $ 5,563 | $ 8,995 |
| Weighted-average fair value of stock options granted (in usd per share) | $ 37.87 | $ 28.94 | $ 11.52 |
| Stock-based compensation expense | $ 15,046 | $ 8,716 | $ 1,933 |
| Income tax benefit from stock-based compensation expense | $ 659 | $ 4,932 | $ 2,826 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of tax benefit for recognition of expense of award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow from exercise of option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|